Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.nejm.org › doi › fullEffect of Early Treatment with Ivermectin among Patients with...

   www.nejm.org › doi › full

   30 mar 2022 · Although various interventions were assessed in this trial, we report here on the use of ivermectin at a dose of 400 μg per kilogram of body weight for 3 days as compared with placebo.

   • Original Article Two Phase 3 Trials of Baricitinib for Alopecia Areata B. King and Others

     We enrolled 654 patients in the BRAVE-AA1 trial and 546 in...

   • Images in Clinical Medicine Primary Cutaneous Blastomycosis A. Alhatem and K.C. Smith

     A 53-year-old landscaper presented with a 4-month history of...

   • Perspective Real-World Evidence — Where Are We Now J. Concato and J. Corrigan-Curay

     Notwithstanding ongoing confusion over the concepts of...

   • Clinical Practice Nonspecific Low Back Pain A. Chiarotto and B.W. Koes

     Nonspecific low back pain is diagnosed by ruling out other...

   • Editorial Baricitinib in Alopecia Areata A. Messenger and M. Harries

     For many people, alopecia areata is a transient problem, in...

   • Clinical Problem-Solving Looking Back L. Glick and Others

     On examination, the temperature was 36.1°C, the blood...

   • Correspondence Dec 15, 2022 Ivermectin Treatment for Covid-19

     Given the wide availability and low cost of ivermectin and...

   • Editorial Audio Interview

     In this audio interview conducted on May 2, 2022, the...

2. pubmed.ncbi.nlm.nih.gov › 34145166Ivermectin for Prevention and Treatment of COVID-19 Infection: A...

   pubmed.ncbi.nlm.nih.gov › 34145166

   21 cze 2021 · Moderate-certainty evidence finds that large reductions in COVID-19 deaths are possible using ivermectin. Using ivermectin early in the clinical course may reduce numbers progressing to severe disease.

3. journals.lww.com › americantherapeutics › FulltextIvermectin for Prevention and Treatment of COVID-19 Infectio ......

   journals.lww.com › americantherapeutics › Fulltext

   The aim of this review was to assess the efficacy of ivermectin treatment among people with COVID-19 infection and as a prophylaxis among people at higher risk of COVID-19 infection. In addition, we aimed to prepare a brief economic commentary (BEC) of ivermectin as treatment and as prophylaxis for COVID-19. 25.

4. www.sciencedirect.com › science › articleEfficacy and safety of ivermectin for treatment of...

   www.sciencedirect.com › science › article

   1 sie 2024 · Efficacy of single-dose and double-dose ivermectin early treatment in preventing progression to hospitalization in mild COVID-19: a multi-arm, parallel-group randomized, double-blind, placebo-controlled trial

5. www.nejm.org › doi › fullIvermectin Treatment for Covid-19 | NEJM - New England Journal of...

   www.nejm.org › doi › full

   14 gru 2022 · Given the wide availability and low cost of ivermectin and that the dosage used in the trial appeared to be safe, such treatment effects could be an important benefit for high-risk patients who...

6. www.ncbi.nlm.nih.gov › pmc › articlesIvermectin as a SARS-CoV-2 Pre-Exposure Prophylaxis Method in ...

   www.ncbi.nlm.nih.gov › pmc › articles

   26 sie 2021 · Kaplan-Meier risk analysis showed that the prevention with ivermectin occurred after the second dose was received on day eight. This finding could suggest that to achieve a preventive dose of ivermectin in the tissues, a second dose is needed (Figure (Figure2 2).

7. www.nejm.org › doi › fullToxic Effects from Ivermectin Use Associated with Prevention and...

   www.nejm.org › doi › full

   20 paź 2021 · The dose of the human-use tablets was 21 mg per dose twice weekly for prevention. Six of the 21 persons were hospitalized for toxic effects from ivermectin use; all 6 reported preventive use,...